BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1173788)

  • 1. Editorial: hyperthyroidism and Grave's disease.
    Br Med J; 1975 May; 2(5969):457-8. PubMed ID: 1173788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M; Vanhaelst L
    J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological determination of thyrotropin and long-acting thyroid simulator].
    Potin VV; Stepanov GS
    Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral and genetic factors in thyrotoxic Graves disease and neonatal thyrotoxicosis.
    Green WL
    JAMA; 1976 Apr; 235(14):1449-50. PubMed ID: 946443
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid stimulating immunoglobulin (TSI) in Graves' disease.
    Ochi Y; Inui T; Kouki T; Yamashiro K; Hachiya T; Kajita Y
    Endocr J; 1998 Dec; 45(6):701-8. PubMed ID: 10395224
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiology of hyperthyroidism].
    Lemarchand-Béraud T; Vannotti A; Griessen M
    Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
    Földes J; Takó J; Bános C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Placental transmission of L. A. T. S. protector.
    Dirmikis SM; Munro DS; Hiller EJ; Crawford MJ; Wynne J; Purcell M
    Lancet; 1974 Dec; 2(7896):1579-80. PubMed ID: 4141025
    [No Abstract]   [Full Text] [Related]  

  • 10. The long-acting thyroid stimulator.
    Kriss JP
    Calif Med; 1968 Sep; 109(3):202-13. PubMed ID: 4235081
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 12. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
    McKenzie JM
    Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.
    Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thyroid-stimulating antibodies].
    S Afr Med J; 1979 Nov; 56(20):781. PubMed ID: 583083
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
    Lamberg BA; Gordin A; Viherkoski M; Kvist G
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
    Sawhney RC; Kannan V; Rastogi GK
    J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-acting thyroid stimulator in Graves' disease.
    Sellers EA; Awad AG; Schönbaum E
    Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.